Literature DB >> 336887

Arthritis and osteomyelitis due to Candida albicans: a case report.

Y Lertratanakul, G H Glassford, H M Rubinstein.   

Abstract

A case of Candida albicans arthritis involving a knee and cuneiform bone is presented. As with other forms of candidiasis, multiple antibiotic treatment and hyperalimentation predisposed to the infection. Fourteen previously published cases are reviewed. The knee is the most common site of infection and there is a high frequency of associated osteomyelitis. Treatment with both amphotericin and 5-fluorocytosine seems to be effective. The case presented was treated successfully with a small dose of amphotericin followed by five and one-half months of 5-fluorocytosine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 336887

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Candida arthritis: cellular immune responses of synovial fluid and peripheral blood lymphocytes to Candida albicans.

Authors:  E Hermann; W J Mayet; O Klein; A W Lohse; C Trautwein; I Michiels; T Poralla; K H Meyer zum Büschenfelde
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

2.  Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011).

Authors:  Maria N Gamaletsou; Dimitrios P Kontoyiannis; Nikolaos V Sipsas; Brad Moriyama; Elizabeth Alexander; Emmanuel Roilides; Barry Brause; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2012-08-21       Impact factor: 9.079

3.  Neonatal and infantile candidal arthritis with or without osteomyelitis: a clinical and radiographical review of 21 cases.

Authors:  D K Yousefzadeh; J H Jackson
Journal:  Skeletal Radiol       Date:  1980-04       Impact factor: 2.199

4.  Candida Arthritis: Analysis of 112 Pediatric and Adult Cases.

Authors:  Maria N Gamaletsou; Blandine Rammaert; Marimelle A Bueno; Nikolaos V Sipsas; Brad Moriyama; Dimitrios P Kontoyiannis; Emmanuel Roilides; Valerie Zeller; Saad J Taj-Aldeen; Andy O Miller; Ruta Petraitiene; Olivier Lortholary; Thomas J Walsh
Journal:  Open Forum Infect Dis       Date:  2015-12-23       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.